» Articles » PMID: 30359093

Clinical 7 T MRI: Are We There Yet? A Review About Magnetic Resonance Imaging at Ultra-high Field

Overview
Journal Br J Radiol
Specialty Radiology
Date 2018 Oct 26
PMID 30359093
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, ultra-high field MRI (7 T and above) has received more interest for clinical imaging. Indeed, a number of studies have shown the benefits from the application of this powerful tool not only for research purposes, but also in realms of improved diagnostics and patient management. The increased signal-to-noise ratio and higher spatial resolution compared with conventional and high-field clinical scanners allow imaging of small anatomical detail and subtle pathological findings. Furthermore, greater spectral resolution achieved at ultra-high field allows the resolution of metabolites for MR spectroscopic imaging. All these advantages have a significant impact on many neurological diseases, including multiple sclerosis, cerebrovascular disease, brain tumors, epilepsy and neurodegenerative diseases, in part because the pathology can be subtle and lesions small in these diseases, therefore having higher signal and resolution will help lesion detection. In this review, we discuss the main clinical neurological applications and some technical challenges which remain with ultra-high field MRI.

Citing Articles

Ex vivo ultra-high field magnetic resonance imaging of human epileptogenic specimens from primarily the temporal lobe: A systematic review.

Lemmens M, van Lanen R, Uher D, Colon A, Hoeberigs M, Hoogland G Neuroradiology. 2025; .

PMID: 40056183 DOI: 10.1007/s00234-024-03474-0.


PET, SPECT, and MRI imaging for evaluation of Parkinson's disease.

Gujral J, Gandhi O, Singh S, Ahmed M, Ayubcha C, Werner T Am J Nucl Med Mol Imaging. 2025; 14(6):371-390.

PMID: 39840378 PMC: 11744359. DOI: 10.62347/AICM8774.


Clinical 7 Tesla magnetic resonance imaging: Impact and patient value in neurological disorders.

de Vries E, Hagbohm C, Ouellette R, Granberg T J Intern Med. 2025; 297(3):244-261.

PMID: 39775908 PMC: 11846079. DOI: 10.1111/joim.20059.


Prospective 3D Fat Navigator (FatNav) motion correction for 7T Terra MRI.

Klodowski K, Sengupta A, Dragonu I, Rodgers C NMR Biomed. 2024; 38(1):e5283.

PMID: 39460596 PMC: 11602639. DOI: 10.1002/nbm.5283.


In vivo imaging of the human brain with the Iseult 11.7-T MRI scanner.

Boulant N, Mauconduit F, Gras V, Amadon A, Le Ster C, Luong M Nat Methods. 2024; 21(11):2013-2016.

PMID: 39420141 PMC: 11541209. DOI: 10.1038/s41592-024-02472-7.


References
1.
Pipe J . Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging. Magn Reson Med. 1999; 42(5):963-9. DOI: 10.1002/(sici)1522-2594(199911)42:5<963::aid-mrm17>3.0.co;2-l. View

2.
Kwan P, Brodie M . Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5):314-9. DOI: 10.1056/NEJM200002033420503. View

3.
Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker B . Multiple sclerosis. N Engl J Med. 2000; 343(13):938-52. DOI: 10.1056/NEJM200009283431307. View

4.
Ludecke D, Flitsch J, Knappe U, Saeger W . Cushing's disease: a surgical view. J Neurooncol. 2002; 54(2):151-66. DOI: 10.1023/a:1012909500847. View

5.
Ibrahim T, Lee R, Baertlein B, Abduljalil A, Zhu H, Robitaille P . Effect of RF coil excitation on field inhomogeneity at ultra high fields: a field optimized TEM resonator. Magn Reson Imaging. 2002; 19(10):1339-47. DOI: 10.1016/s0730-725x(01)00404-0. View